脱铁酮
医学
地中海贫血
去铁胺
螯合疗法
输血
中性粒细胞减少症
β地中海贫血
儿科
内科学
化疗
作者
Nadia Waheed,Shafqut Ali,Muhammad Asghar Butt
出处
期刊:PubMed
[National Institutes of Health]
日期:2015-03-17
卷期号:26 (3): 297-300
被引量:19
摘要
Deferiprone is a highly efficacious and safe chelation therapy for patients with thalassemia major who are non-compliant to Deferrioxamine. Deferiprone have an efficacy profile comparable to standard Deferrioxamine.
科研通智能强力驱动
Strongly Powered by AbleSci AI